Team:Montgomery Cougars NJUSA/Extras/References
From 2014hs.igem.org
(→References) |
|||
Line 9: | Line 9: | ||
Oberemok, Steve S., and Alan R. Shalita. "Acne vulgaris, I: pathogenesis and diagnosis." CUTIS-NEW YORK- 70.2 (2002): 101-105. | Oberemok, Steve S., and Alan R. Shalita. "Acne vulgaris, I: pathogenesis and diagnosis." CUTIS-NEW YORK- 70.2 (2002): 101-105. | ||
+ | |||
+ | Ozer Arican, Ergul Belge Kurutas, Sezai Sasmaz. Mediators Inflamm. 2005 December 14; 2005(6): 380–384. doi: 10.1155/MI.2005.380 | ||
{{Montgomery_Cougars_NJUSA/Layout_End:Two_Column}} | {{Montgomery_Cougars_NJUSA/Layout_End:Two_Column}} | ||
{{Montgomery_Cougars_NJUSA/Sidebar}} | {{Montgomery_Cougars_NJUSA/Sidebar}} |
Revision as of 12:36, 26 May 2014
References
Bhatia A, Maisonneuve JF, Persing DH. PROPIONIBACTERIUM ACNES AND CHRONIC DISEASES. In: Institute of Medicine (US) Forum on Microbial Threats; Knobler SL, O'Connor S, Lemon SM, et al., editors. The Infectious Etiology of Chronic Diseases: Defining the Relationship, Enhancing the Research, and Mitigating the Effects: Workshop Summary. Washington (DC): National Academies Press (US); 2004.
Higaki, Shuichi. "Lipase Inhibitors for the Treatment of Acne." Journal of Molecular Catalysis B: Enzymatic 22.5-6 (2003): 377-84. Print.
Lee WL, Shalita AR, Sunthralingam K, et al. Neutrophil chemotaxis to Proprionibacterium acnes lipase and its inhibition. Infect Immun. 1982;35:71–78.
Oberemok, Steve S., and Alan R. Shalita. "Acne vulgaris, I: pathogenesis and diagnosis." CUTIS-NEW YORK- 70.2 (2002): 101-105.
Ozer Arican, Ergul Belge Kurutas, Sezai Sasmaz. Mediators Inflamm. 2005 December 14; 2005(6): 380–384. doi: 10.1155/MI.2005.380
Our Project
- Project Overview
- Pathogenesis of Acne
- Selecting the Gene
- Registry Parts
- Mathematical Model
- Error Analysis
Extras
- Human Practices
- Acknowledgements
- Attributions
- Testimonials
- References
- Fun!